Serum sclerostin and irisin as predictive markers for atherosclerosis in Egyptian type II diabetic female patients: A case control study
Fig 2
(a-d): ROC curve of both SOST and irisin in the 2 studied diabetic groups. (a) ROC curve of SOST in type 2 diabetic patients without atherosclerosis, (b) ROC curve of irisin in type 2 diabetic patients without atherosclerosis, (c) ROC curve of SOST in type 2 diabetic patients with atherosclerosis, and (d) ROC curve of irisin in type 2 diabetic patients with atherosclerosis.